Evidence map›Paper›PMID 32885249›Full record

SynthesisNutrition reviews2021

Zinc supplementation combined with antidepressant drugs for treatment of patients with depression: a systematic review and meta-analysis.

Laís Eloy Machado da Silva, Mônica Leila Portela de Santana, Priscila Ribas de Farias Costa, Emile Miranda Pereira, Carina Márcia Magalhães Nepomuceno, Valterlinda Alves de Oliveira Queiroz, Lucivalda Pereira Magalhães de Oliveira, Maria Ester Pereira da Conceição- Machado, Eduardo Pondé de Sena

Open access · bronzeAbstract readMeta-AnalysisSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Nutrition reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Laís Eloy Machado da SilvaGraduate Program in Food, Nutrition and Health, Federal University of Bahia, Salvador, Brazil.
Mônica Leila Portela de SantanaDepartment of Nutrition Science, Federal University of Bahia, Salvador, Brazil.
Priscila Ribas de Farias CostaDepartment of Nutrition Science, Federal University of Bahia, Salvador, Brazil.
Emile Miranda PereiraGraduate Program in Food, Nutrition and Health, Federal University of Bahia, Salvador, Brazil.
Carina Márcia Magalhães NepomucenoGraduate Program in Food, Nutrition and Health, Federal University of Bahia, Salvador, Brazil.
Valterlinda Alves de Oliveira QueirozDepartment of Nutrition Science, Federal University of Bahia, Salvador, Brazil.
Lucivalda Pereira Magalhães de OliveiraDepartment of Nutrition Science, Federal University of Bahia, Salvador, Brazil.
Maria Ester Pereira da Conceição- MachadoDepartment of Nutrition Science, Federal University of Bahia, Salvador, Brazil.
Eduardo Pondé de SenaDepartment of Pharmacology, Institute of Health Sciences, Federal University of Bahia, Salvador, Brazil.
Universidade Federal da Bahia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextZinc is an essential trace mineral required for the function of brain and neural structures. The role of zinc supplementation in the prevention and treatment of depression has been suggested in clinical studies that reported a reduction in depressive symptoms.

objectiveThe aim of this review was to determine whether zinc supplementation vs placebo can prevent or improve depressive symptoms in children, adolescents, or adults. DATA SOURCES: Five electronic databases were searched, and studies published until September 2019 were included without language restriction. STUDY SELECTION: Randomized, controlled, crossover trials that evaluated the effect of zinc supplementation vs a comparator for prevention or improvement of depressive symptoms in children, adolescents, or adults were eligible for inclusion. DATA EXTRACTION: Two authors independently performed data extraction and risk-of-bias assessment.

resultsThe initial search identified 12 322 studies, 5 of which were eligible for meta-analysis. The standardized mean difference (SMD) showed an average reduction of 0.36 point (95%CI, -0.67 to -0.04) in the intervention group compared with the placebo group. Forstudies in which the mean age of participants was ≥ 40 years, the SMD was reduced by 0.61 point (95%CI, -1.12 to -0.09) in the intervention group vs the placebo group. The meta-analysis by sample size (< 60 individuals and  ≥ 60 individuals) did not show an effect of zinc supplementation in reducing depressive symptoms (SMD -0.28; 95%CI, -0.67 to -0.10; and SMD -0.52; 95%CI, -1.10 to 0.06).

conclusionZinc supplementation may reduce depressive symptoms in individuals treated with antidepressant drugs for clinical depression. SYSTEMATIC REVIEW REGISTRATION: PROSPERO registration number CRD42018081691.

Indexed as

Dietary SupplementsAdolescentAdultAgedAged, 80 and overAntidepressive AgentsChildDepressionHumansMajor Depressive DisorderMiddle AgedTrace ElementsYoung AdultZincAntidepressive AgentsTrace ElementsZincdepressiondepressive symptomsmeta-analysiszinc

Identifiers

PMID32885249
OpenAlexW3083070786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.